Company Also Announces Move into New San Diego HeadquartersSAN DIEGO--(BUSINESS WIRE)--Today, MediPrint™ Ophthalmics, an emerging San Diego-based clinical stage eye care pharmaceutical company focused on enhancing vision for life, announces it has initiated its SIGHT-2 dose-finding Phase 2b study for its proprietary...
Related Keywords
San Diego , California , United States , Orlando Rodrigues , Sanjeev Ganatra , Praful Doshi , Global Research , Company Also Announces , Company Also Announces Move , New San Diego , San Diego Based , Sustained Innovative Glaucoma , Hypertension Treatment , Manoj Vyas , Print Ophthalmic ,
vimarsana.com © 2020. All Rights Reserved.